Body mass and sympathetic activity increase with aging and might underlie blood pressure (BP) elevation. Increased body mass index (BMI) may elevate BP by increasing sympathetic activity. Glutathione (GSH) can decrease BP, and declines with aging. We measured systolic (SBP) and diastolic BP, BMI, plasma (NE pl ) and urine norepinephrine (NE u ), and plasma GSH in n ¼ 204 twins across the age spectrum. BP correlated directly with BMI, NE pl , and NE u , but inversely with GSH. Age correlated with BP, BMI, NE pl , and NE u . BP, BMI, NE pl , and NE u were higher in older subjects than younger subjects, whereas GSH was lower with aging. In older subjects with high (above median) NE pl , SBP was 8 mmHg higher than in those of comparable age with low NE. In younger subjects with high GSH, BP was significantly lower than in younger subjects having low GSH. NE u was significantly reduced in young high-BMI subjects vs young low-BMI subjects. The heritability (h 2 ) of NE pl, NE u , and GSH ranged from B50 to B70%, and these biochemical quantities were considerably more heritable than BP. We conclude that increases in sympathetic activity contribute to aging-induced SBP elevations, especially in older females. GSH reductions apparently participate in aging-induced BP elevations, most strongly in males. BMI increases contribute to BP elevations, particularly in younger subjects. BMI elevations apparently raise BP mainly by peripheral mechanisms, with generally little sympathetic activation. Substantial h 2 for plasma GSH, NE, and urine NE suggests that such traits may be useful 'intermediate phenotypes' in the search for genetic determinants of BP.
Introduction
In western civilizations, blood pressure (BP) and cardiovascular disease increase with aging. The increase in BP may be due, in part, to the gradual weight gain that typically accompanies aging, 1 as BP is highly related to both body mass index (BMI) and body fat depots. 2 The mechanism by which increased BMI elevates BP is uncertain. The hormone leptin increases with elevated BMI and may elevate BP either directly, or through sympathetic activation. [3] [4] [5] [6] Obesity-induced augmentation of sympathetic activity might be a homeostatic mechanism to normalize body mass 7, 8 by increasing beta-adrenergic receptor-mediated thermogenesis. 9 Obesityinduced activation of vascular sympathetic nerves may also increase BP via chronic vasoconstriction. 10 However, the ability of obesity and leptin to augment the overall sympathetic activity in humans is controversial. It is supported by some studies, 11, 12 but not by others. [13] [14] [15] Some of these apparent inconsistencies may be due to race-and genderspecific effects.
Although it is unclear whether obesity increases sympathetic activity in man, gradual significant increases in plasma norepinephrine (NE) appear to accompany aging in resting normotensive man, 16, 17 though this finding is not universal. 18, 19 It is also unclear if the NE elevations in older subjects raise their BP. Such plasma NE elevations in the elderly may simply be due to reduced NE removal from plasma, and would therefore have little effect on BP, since synaptic NE levels might not be increased.
Most studies using radiotracer methodology to determine the effects of aging on whole body NE release from sympathetic nerves indicate that the overall NE release is not enhanced by aging at rest [20] [21] [22] [23] or with mental stress. 24 However, one study did find increased resting NE release with aging. 25 NE spillover from the synapse into plasma is selectively enhanced with aging in several vascular beds, including those of the heart 20, 21, 24, 26 and hepatomesenteric area. 20, 23 In the heart, this is at least partially due to reduced intrasynaptic reuptake of NE, 24, 27 suggesting that the sympathetic drive is chronically increased in the aging heart. Increased sympathetic tone to aging muscle is also suggested by recordings showing increased sympathetic burst activity in this tissue. 18, 28, 29 However, it is unclear if increased sympathetic activity in muscle leads to sufficient chronic vasoconstriction to raise BP.
The BP elevation with aging may also be partially independent of obesity. Blood vessels generally become stiffer with aging. This is due in part to increases in vessel thickness and to the progression of atherosclerotic processes. [30] [31] [32] Some loss of distensibility may also be due to reduced beta receptormediated vasodilation with aging. 33 An additional factor may be a decreased capacity for endothelial-mediated vasodilation with aging. [34] [35] [36] Endothelium-mediated vasodilation is largely due to nitric oxide (NO), which can be decreased by oxygen-free radicals. 37, 38 With aging, there is a reduction in the efficacy of the body's defenses against these free radicals. [39] [40] [41] Levels of the potent antioxidant reduced glutathione (GSH) and its synthetic enzymes are decreased with aging in plasma [42] [43] [44] and several tissues, 42, [45] [46] [47] [48] including the brain. 49 Treatments that reduce GSH synthesis increase BP, [50] [51] [52] and GSH has vasodilating and antihypertensive actions. [53] [54] [55] So, reductions in GSH may play an important role in age-related increases in BP.
It is unclear whether the antihypertensive actions of GSH are central or peripheral in origin. Disruption of CNS GSH synthesis appears to raise BP in rodents by increasing sympathetic outflow. 51 However, other rodent data suggest that GSH might reduce BP via a peripheral action by reducing the rate of breakdown of NO. 55 Plasma GSH may influence brain GSH as there appears to be specific transport of GSH across the blood-brain barrier. 56 There is also reason to believe that the relationship between BP and aging may differ considerably between males and females. The incidence of cardiovascular disease is lower in females than males, and this gender difference is apparently less following menopause. 57 In fact, the incidence of isolated systolic hypertension may be higher in elderly females than males. 58 A major factor contributing to this gender difference appears to be reduced estrogens following menopause. Estrogens suppress vasoconstriction in response to a variety of agonists, [59] [60] [61] and this may be due to increases in vascular NO induced by estrogens. 59, [62] [63] [64] [65] Vasoconstriction is increased post-menopause in females. 60 In vitro, NE-mediated vasoconstriction in blood vessels from elderly females is actually greater than from vessels of elderly men. 66 Furthermore, menopause causes blood vessels to thicken and stiffen, 67 and this may be due to the reductions in estrogens that accompany menopause. 68, 69 Estrogen reduction may also contribute to enhanced sympathetic nerve activity in post-menopausal females. 61, 70, 71 Another way the relationship between obesity and sympathetic activity is likely to differ between the sexes is that women have several-fold higher leptin levels than men. 72 So if leptin raises sympathetic activity equally in both sexes, one would expect much higher plasma NE in females than males, but this is not the case.
The increase in BP with aging may also be partially under genetic control. Both systolic (SBP) and diastolic BP (DBP) have generally been reported to have moderate heritability, despite their tendency to increase with aging. 73 Similarly, both sympathetic activity 74 and vascular responsiveness to NE 75 appear to be moderately heritable. Despite its tendency to increase with aging, BMI is also heritable to a rather large extent. 76 In this study, we examined the relationships of BP with plasma NE, urine NE, plasma GSH, and BMI in a population of n ¼ 204 male and female twins. Our study was principally focused on addressing how changes in NE and GSH with aging relate to BP and BMI, and the extent to which these relationships are influenced by gender and heredity. We compared the levels of these parameters in younger (belowmedian age) subjects with those in older (abovemedian age) subjects, and in males vs females. We also compared how strongly these parameters correlated with each other in young vs old subjects, and in males vs females. Furthermore, we split the subjects into those with high (above median) vs low (below median) levels of a particular parameter and determined the extent to which this split generated changes in the other parameters of interest. Heritability of BP, BMI, plasma NE, GSH, and urine NE was also calculated. The data suggest that there are strong relationships of BP with NE, GSH, and BMI that are markedly influenced by age, gender, and genetics.
Methods

Subjects
Traits were determined in n ¼ 204 subjects, of whom 142 were monozygotic twins and 62 were dizygotic twins. Subjects for this study were part of an ongoing study on the genetics of hypertension.
Subjects were recruited from a population birth record-based twin registry and from newspaper advertisements, as described previously. 77 Informed consent was obtained from all subjects prior to their enrollment into the study. Male and female subjects included in the current study were selected such that, overall, male and females were of comparable age. Characteristics of the study subjects are given in Table 1 . Untimed urine samples were collected from each subject; urine was quickly frozen and stored at À701C until assayed for NE, GSH, and creatinine. An indwelling catheter was inserted into an antecubital vein of each subject, who then remained in a recumbent position for at least 5 min before blood was drawn into an EDTA tube and placed on ice.
Assays
Within 1 h the refrigerated, EDTA-anticoagulated blood was centrifuged and the resulting plasma was removed and stored at À701C until assayed for NE by the radioenzymatic method of Kennedy and Ziegler. 78 The catecholamine assay involved transfer of a tritium label to catecholamines from tritiated S-adenosylmethionine during O-methylation mediated by the enzyme catechol O-methyltransferase (COMT). Prior to O-methylation, the plasma catecholamines were extracted into dilute acetic acid to remove COMT inhibitors present in plasma. All urine NE values were corrected for variations in creatinine and are reported as such.
Reduced glutathione (GSH; Glu-Cys-Gly) was determined in plasma using a high-performance liquid chromatography (HPLC) method with fluorescence detection. 79 Briefly, the method consists of reduction of the sample with tri-n-butylphosphine, precipitation of proteins with perchloric acid, and derivatization with 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate (SBDF). The thiol SBDF derivatives are separated on a reverse-phase C18 column (Prodigy 5 m ODS(2) 150 Â 2 mm, Phenomenex, CA, USA) by isocratic elution at a flow rate of 0.3 ml/min and detected by fluorescence (excitation 390 and emission 515). Quantitation is performed using D,Lhomocysteine and GSH (reduced form) as external calibration standards.
BP measurement
BP (in mmHg) was recorded continuously and noninvasively for 5 min in seated subjects, with a radial artery applanation device and dedicated sensor hardware (Colin Pilot; Colin Instruments, San Antonio, TX, USA) and software (ATLAS from WR Medical, Stillwater, MN, USA; and Autonomic Nervous System/Tonometric Data Analysis (ANS/ TDA) from Colin Instruments), calibrated every 5 min against ipsilateral brachial arterial pressure with a cuff sphygmomanometer.
Statistics
The significance of intergroup differences was determined by the Student's t-test using PC!info statistical software (Redmond, Washington). The criterion for significance was Pp0.05 in all analyses.
Heritability is the % of trait variance accounted for by additive genetic variance. 77 The heritability of each trait was determined from monozygotic (MZ) and dizygotic (DZ) twin trait values, using the variance components Sequential Oligogenic Linkage Routines (SOLAR) algorithm, available at the SO-LAR website (http://www.sfbr.org/solar/). SOLAR is designed for the analysis of twin and family data, in which family (or twinship) members are not genetically independent; indeed, SOLAR takes advantage of MZ and DZ twin pair correlations to estimate heritability.
Pearson's correlation coefficient was used to determine the significance of correlations between parameters and was performed using PC!info. Since the participants are twins, and therefore not genetically independent, the effective number of individuals for any characteristic with substantial heritability may be less than the total number of individuals; thus, the significance (though not the magnitude) of correlations may be overestimated. Even if the effective number of individuals is only 1/2 of the total number, Po0.025 would correspond to a standard Po0.05 threshold. In some instances, these correlations were adjusted for contributions made by other parameters in an attempt to determine causal relationships among the parameters. Many correlations were performed in this study, and it is conceivable that this raises the chance of false significance. Since many of our variables and tests are interdependent (cross-correlated), adjustment of the significance of our results with a Bonferroni correction would be inappropriate, since it would be overly conservative. A Bonferroni correction for two comparisons would yield a modified threshold 
Results
Descriptive statistics and BP correlations
Several characteristics of our study subjects are listed in Table 1 . Female subjects had significantly lower pulse pressure (PP) (Po0.001) than males. In subjects overall, SBP and DBP correlated positively with BMI, plasma norepinephrine concentration (NE pl ), and urinary norepinephrine excretion (NE u ), and inversely with GSH ( Table 2 ). Age correlated with BP, NE pl , and NE u ( Table 2 ). The correlation of age with SBP remained highly significant after controlling for variations in NE pl , NE u , GSH, or BMI (r ¼ 0.206, Po0.005). The correlation of age with DBP also remained significant after adjusting for NE pl , NE u , GSH, or BMI (r ¼ 0.298, Po0.001). GSH correlated inversely with BMI ( Table 2 ). The combined correlation coefficient by MLR of NE pl þ GSH with SBP, DBP, age, and BMI individually was statistically significant in all cases (r ¼ 0.229, P ¼ 0.012).
Correlations: gender effects
Most of the correlations among SBP, DBP, age, BMI, GSH, NE pl , and NE u were of similar magnitude in both sexes (Table 3 ). However, the strength of the correlation of NE pl with SBP, DBP, and age was roughly twice as strong in women as men, and was significant only in women. In contrast, the correlation of NE u with SBP and age was more than twice as 
Correlations: age effects
Both NE pl and NE u correlated significantly with SBP only in older (above-median age) subjects (Table 4 ). The correlation of NE pl with SBP remained significant after controlling for age (r ¼ 0.210, P ¼ 0.05) or age plus BMI (r ¼ 0.268, P ¼ 0.013). The inverse correlation of GSH with SBP and DBP was much stronger and was statistically significant only in younger (below-median age) subjects (Table 4 ). The correlation of GSH with SBP remained significant after adjusting for subject age (r ¼ À0.257, P ¼ 0.021), but was of borderline significance after controlling for BMI (r ¼ À0.211, P ¼ 0.06) or age plus BMI (r ¼ À0.219, P ¼ 0.053). The correlation of BMI with SBP was much stronger and statistically significant only in young subjects (Table 4 ). This correlation of BMI with SBP remained highly significant (Po0.001) even after controlling for NE pl , NE u , GSH, or age. The correlation of age with SBP was much stronger and was significant only in older subjects ( Table 4 ). The combined correlation coefficient by MLR of NE pl þ GSH þ age þ BMI with either SBP or DBP was significant in both younger (r ¼ 0.451, Pp0.001) and older (r ¼ 0.431, P ¼ 0.003) subjects.
Correlations: interactions of age and gender
The dramatically stronger correlation of BMI with SBP and DBP in younger subjects was true in both men and women (Table 5 ). In contrast, the correlation between SBP and NE pl was much stronger in elderly women than men (Table 5) . Conversely, the correlation between NE u and SBP was stronger in elderly men than women. In older (above-median age) females NE pl significantly correlated with SBP (r ¼ 0.252, P ¼ 0.04), whereas in younger females NE pl levels did not correlate (r ¼ À0.051, P ¼ 0.675) with SBP (Table 5 ). In older males there was a negligible correlation of NE pl with either SBP (r ¼ 0.031,
In younger males, the correlation of NE pl with SBP or DBP was also not statistically significant (P40.17).
In younger females, plasma GSH was inversely correlated with SBP (r ¼ À0.305, P ¼ 0.015), but not in older females (r ¼ 0.016, P ¼ 0.9) ( Table 5 ). Correlations of GSH with SBP were fairly strong in both younger (r ¼ À0.368, P ¼ 0.122) and older (r ¼ À0.222, P ¼ 0.348) males, but did not reach statistical significance. The combined correlation by MLR of NE pl þ GSH þ age þ BMI with either SBP or DBP was significant in both younger and older women (r ¼ 0.42, Pp0.001). A similar MLR in males was significant only in younger males, and this MLR correlation coefficient was quite high (r ¼ 0.71, P ¼ 0.03).
Heritability
The heritability (h 2 ) of such biochemical traits as NE pl , NE u , and plasma GSH ranged from about 50 to Correlations of SBP and DBP with NE pl , NE u , GSH, age, and BMI in subjects of below-median age (younger) or above-median age (older). The median age was 38 years. NE pl +GSH+age+BMI is a MLR determining the combined influence of NE pl , GSH, age, and BMI (four independent variables) on the single dependent variables SBP or DBP, in younger or older subjects. Bold indicates statistical significance (Po0.05).
Heritability, glutathione, catecholamines, blood pressure and aging BP Kennedy et al 70%, and these heritability estimates were all highly statistically significant (Po0.0001) ( Figure 1 , Table 6 ). The percent heritability of BMI in our subjects was greater than 83% (Po0.0001), and was slightly, but significantly, influenced by subject age. In contrast, the heritability of the physiological traits SBP (22.6%, P ¼ 0.0082) and DBP (17.8%, P ¼ 0.08) was considerably less than that of the biochemical traits. BP heritability was moderately (B15-20%) influenced by age. The heritability of urine NE was influenced about 17% by subject age.
Trait means: stratification by age, norepinephrine, GSH, BMI, and gender
In older (above-median age) subjects, SBP, DBP, NE pl , NE u , and BMI were all significantly higher, whereas GSH was significantly lower than in young (below-median age) subjects ( Figure 2 ). Older subjects who had higher (above median) levels of NE pl had significantly higher SBP than older subjects with lower NE (Figure 3 , left column). However, SBP was not significantly different when younger subjects with higher NE were compared with younger subjects with lower NE (Figure 3 , left column). Older subjects with higher NE pl had NE levels that were 31% (Po0.001) higher than younger subjects with high NE, and also had significantly (Po0.001) higher SBP than younger subjects with Heritability, glutathione, catecholamines, blood pressure and aging BP Kennedy et al high NE (Figure 3 ). Older subjects with high NE pl had significantly lower BMI than older subjects with low NE (Figure 3 ). When a similar analysis was performed only on females, it was found that older females with high NE pl had SBP that was about 8 mmHg higher (P ¼ 0.015) than in older low NE females (126.971.8 vs 135.072.6 mmHg). In contrast, high NE pl younger females tended to have lower SBP than low NE younger females (125.972.4 vs 121.872.1 mmHg). The BP differences between high NE pl males and low NE males were not significant, regardless of age grouping. Older subjects with higher (above median) urine NE levels had significantly (P ¼ 0.003) higher SBP than younger subjects with high urine NE levels ( Figure 3 , right column). In contrast, older subjects with low urine NE levels had SBP that was similar to younger subjects with low NE levels.
Younger subjects who had high levels of plasma GSH had significantly lower SBP and DBP than younger subjects with low GSH (Figure 4 ). Older subjects with high GSH had significantly higher SBP and DBP than younger subjects with high GSH (Figure 4 ). BMI was not significantly different in subjects with high GSH compared with subjects having low GSH, regardless of whether subjects were young or old (Figure 4) . Plasma NE tended to increase in high GSH subjects, and this effect reached statistical significance in the younger subjects (Figure 4 ).
Younger subjects with high BMI had significantly (B10 mmHg) higher SBP than younger subjects with low BMI (Figure 5 ). Older subjects with high BMI had SBP that was 5 mmHg higher than older low BMI subjects, but this effect did not reach statistical significance (P ¼ 0.091) ( Figure 5 ). When this analysis was confined to females, it was found that young females with high BMI had significantly higher SBP than young females with low BMI (118.771.95 vs 129.272.2 mmHg, Po0.001), but SBP was not significantly increased in older females with high BMI compared to older females with low BMI (128.772.4 vs 133.172.0 mmHg, P ¼ 0.167). NE u was significantly reduced (P ¼ 0.012) in young subjects with high BMI relative to young subjects with low BMI.
In older (above-median age) subjects, the correlation of BMI with SBP was not statistically significant (r ¼ 0.182, P ¼ 0.071). However, after correction for variations in NE pl , the strength of the correlation was markedly increased (r ¼ 0.250, P ¼ 0.019). In younger subjects, correction for NE pl had little impact on the strength of the correlation between BMI and SBP: r ¼ 0.517 (Po0.0001) vs r ¼ 0.508 (Po0.0001) after correction. Similarly, correcting for NE pl enhanced the correlation of SBP with BMI in older females (r ¼ 0.245, P ¼ 0.048 after correction vs r ¼ 0.171, P ¼ 0.143), but NE pl correction did not markedly alter the SBP correlation with BMI in younger females (r ¼ 0.504, Po0.0001 corrected vs r ¼ 0.512, Po0.0001 uncorrected).
Older (above-median age) females had a highly significant (Po0.001) increase in SBP of about 7 mmHg vs younger women, whereas the increase in SBP in older males vs the younger men did not reach statistical significance ( Figure 6 ). In contrast, both older males and older females had highly significant (Po0.001) increases in DBP vs the younger subjects, and the increase in DBP in males was more than twice as large as in females (11.3 vs 5.1 mmHg) ( Figure 6 ). PP was not significantly increased in older vs younger subjects of either sex. However, PP was significantly (Po0.001) lower in young females (5571.1 mmHg) than in young males (63.571.9 mmHg). Older females had NE pl levels that were 91 pg/ml (Po0.001) higher than younger females. However, older males had NE pl levels that were unchanged from younger males (P40.3) ( Figure 5 ). NE pl was significantly lower in young females than in young males ( Figure 6 ). Older men and women had significantly increased NE u vs younger men and women, respectively ( Figure 6 ). Older males had significantly reduced GSH (P ¼ 0.004) vs younger males. In contrast, GSH in older females did not differ significantly from young females ( Figure 6 ). BMI was significantly higher in older vs younger females, but this was not true in males ( Figure 6 ). Figure 2 Influence of age on SBP, DBP, plasma GSH, plasma NE, urine NE, and BMI in younger (below-median age) and older (abovemedian age) subjects. Each value is the mean7s.e.m. of n ¼ 85-102 determinations. Statistical significance was determined by t-test. The median age was 38 years.
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Females with high (above median) SBP had NE pl levels that were about 70 pg/ml (P ¼ 0.009) higher than females with low SBP (Figure 7) . In contrast, males with above-median SBP had NE pl levels that were not significantly higher than males with below-median SBP. Urine NE was significantly (Left column) SBP, DBP, BMI, GSH, and NE levels in younger (below-median age) and older (above-median age) subjects that have each been split into subgroups with above-median (HI NE) or below-median (LO NE) plasma NE levels. Graphs in the right column show the same parameter after subjects were divided into groups with above-or belowmedian urine NE levels. Each value is the mean7s.e.m. of n ¼ 43-51 determinations. Statistical significance was determined by t-test. ***Po0.001 vs young subjects with high NE. elevated in both men and women with high (above the median) SBP relative to men and women with low SBP.
In males with high (above median) DBP, plasma GSH levels were reduced by more than 30% (P ¼ 0.011) compared to males with low DBP, whereas high DBP females had GSH that was not significantly different from females with low DBP (Figure 8 ). High DBP subjects had increases in BMI compared to low DBP subjects that were comparable in both sexes (males: 23 In our subjects overall, neither NE pl nor NE u correlated significantly with BMI (r ¼ À0.101, P ¼ 0.168; r ¼ 0.098, P ¼ 0.118, respectively). NE pl was significantly inversely correlated with BMI in females (r ¼ À0.165, P ¼ 0.05), but NE u was not (r ¼ 0.090, P ¼ 0.300). BMI in males did not correlate with either NE pl (r ¼ 0.092, P ¼ 0.54) or NE u (r ¼ 0.166, P ¼ 0.270) ( Table 3 ). The inverse correlation of BMI with NE pl was much stronger in older (above-median age) females (r ¼ À0.311, P ¼ 0.009), and older subjects overall (r ¼ À0.239, P ¼ 0.023), than young females (r ¼ 0.032, P ¼ 0.72). BMI was not significantly correlated with NE u in either older (r ¼ 0.111, P ¼ 0.377) or younger (r ¼ 0.292, P ¼ 0.176) females. BMI in young (below-median age) males was not significantly correlated with either plasma NE (r ¼ 0.118, P ¼ 0.602) or NE u (r ¼ À0.283, P ¼ 0.191). Similarly, BMI in older males was not significantly correlated with either NE pl (r ¼ 0.180, P ¼ 0.401) or NE u (r ¼ 0.292, P ¼ 0.176).
Urine creatinine concentration was significantly (Po0.001) higher in males than females (1.3170.11 vs 0.9470.047 mg/ml). Though creatinine correlated inversely with age to a similar extent in both men (r ¼ À0.263, P ¼ 0.063) and women (r ¼ À0.234, Po0.001), urine creatinine was significantly reduced in older vs younger females (0.8370.06 vs 1.1170.09 mg/ml) but not in older men vs younger men (1.3470.16 vs 1.2770.15, P40.3). The correlation between NE pl and NE u was particularly strong in women with above-median urine creatinine (r ¼ 0.53, Po0.001) and also in men with abovemedian creatinine (r ¼ 0.407, P ¼ 0.054). The correlation of NE pl with NE u was particularly weak in low-creatinine men (r ¼ 0.110, P ¼ 0.645), but was still fairly strong in low-creatinine women (r ¼ 0.353, Po0.001). Men with below-median urine creatinine had NE u levels that were 38% higher (P ¼ 0.006) than men with low urine creatinine (29.772.7 vs 21.171.2 ng/mg). Similarly, women with below-median urine creatinine had NE u levels Figure 4 Combined influence of age and GSH. SBP, DBP, BMI, plasma NE, urine NE, and plasma GSH levels are shown in young (below-median age) and old (above-median age) subjects that have each been split into subgroups with above-median (high) or below-median (low) plasma GSH levels. Each value is the mean7s.e.m. of n ¼ 43-51 determinations. Statistical significance was determined by t-test. ***Po0.001 vs older subjects with high GSH. **P ¼ 0.007 vs older subjects with high GSH. P<.036 Figure 5 Combined influence of age and BMI. SBP, DBP, BMI, plasma GSH, plasma NE, and urine NE are shown in young (below-median age) and old (above-median age) subjects that have each been split into subgroups with above-median (high) or below-median (low) plasma BMI levels. Each value is the mean7s.e.m. of n ¼ 43-51 determinations. P<.001 * * Figure 6 Combined influence of age and gender. SBP, DBP, BMI, plasma GSH, plasma NE, and urine NE are shown in young (below-median age) and old (above-median age) men and women. Each value is the mean7s.e.m. of n ¼ 43-51 determinations. 
Discussion
Determinants of BP elevation with advancing age
The data suggest that increased sympathetic activity plays a significant role in the SBP elevation with aging, especially in females. BMI increases also appear to contribute to aging-induced BP elevations, but the pressor effect of obesity is less dramatic in the elderly. Reductions in plasma GSH may also contribute to increases in BP with aging, most strongly in younger adults and males. The heritability of SBP and DBP in our subjects ranges from about 18 to 28%, but the heritability of several biochemical traits (urine and plasma NE and GSH) known to influence BP is substantially higher. Greater heritability of NE and GSH than BP ( Figure 1 , Table 6 ) suggests that these potentially pathophysiological traits may be early 'intermediate phenotypes' 80 useful in the search for genetic determinants of BP.
Sympathetic activity
There are several findings from the present study that together provide compelling evidence for a role of augmented sympathetic activity in aging-related SBP elevation. On the most basic level, SBP, plasma NE, and urine NE were all significantly elevated in older subjects vs younger subjects (Figure 2 ). In addition, there was a significant correlation of SBP with both plasma NE and urine NE in older, but not younger, subjects (Table 4 ). This correlation of plasma NE with SBP was statistically significant even after controlling for subject age or BMI. Older subjects with high (above average) urine NE had significantly higher SBP than younger subjects having high urine NE (Figure 3) . Finally, older subjects with high plasma NE also had significantly higher SBP than older subjects with low plasma NE (Figure 3 ).
There are several potential mechanisms which might cause the strong association of NE and SBP in older subjects. One such mechanism may be selective activation of cardiac sympathetic nerves with aging. 20, 21, 24, 26, 27 This may lead to increases in the force of ventricular contraction and thus selective elevation of SBP. Even though the heart is a small contributor to plasma and urinary NE overall, the increase in heart spillover with aging appears to be regulated by the same central processes that mediate the increase in NE spillover in larger vascular beds such as the hepatomesenteric. 20 Coordinated sympathetic activation to several vascular beds along with the heart may underlie the correlation of SBP with plasma and urinary NE in older subjects.
Another potential mechanism for the increased role of NE in controlling SBP in the elderly may be that blood vessels become less compliant with aging, 81 particularly in post-menopausal females. 82, 83 SBP increases when blood vessels are less distensible because the surge in blood flow with ventricular contraction is less readily absorbed by inflexible vessel walls.
The relationship between the aging-associated increase in SBP and plasma NE elevations seems to be especially strong in women. Older females had significantly elevated SBP and plasma NE levels relative to younger women, but this was not the case in men (Figure 6 ). Furthermore, plasma NE correlated significantly with SBP in older women, but not older men (Table 5) . One potential explanation for these findings may be the greater increase in vascular stiffness in females than males with aging. 66 This, in turn, may be due to the decrease in estrogens which accompanies menopause. Our older (above-median age) females averaged B47 years, and ranged from 38 to 60 years. So this group was largely post-menopausal, whereas our younger females averaged about 25 years, ranged from 14 to 37, and were therefore mainly pre-menopausal. Prior studies suggest that estrogens can suppress both the magnitude of NE-mediated vasoconstriction 60, 61 and the rate of firing of sympathetic nerves. 61, 70, 71 So the estrogen depletion in our postmenopausal women is likely to underlie at least part of the enhanced plasma NE and urine NE in our postmenopausal females. Our data also appear to suggest that the greater incidence of isolated systolic hypertension in elderly females may be due in part to increased sympathetic activity and augmented systolic pressor responsiveness resulting from decreased postmenopausal estrogens.
One factor that influences plasma NE levels is the baroreceptor system, which reduces sympathetic outflow when BP increases above normal levels due to pressor actions in the periphery. However, our data do not indicate that baroreceptors play a strong role in antagonizing the increased NE levels in elderly females. Baroreceptors typically respond to peripheral increases in BP by reducing sympathetic outflow (and thus plasma NE) from the CNS. Even though SBP was elevated in elderly vs younger women, plasma NE levels were still higher in elderly females than younger females. This is the opposite of what one might expect if baroreceptors were reducing sympathetic outflow in response to increased SBP in elderly females. It may be that baroreceptors may be less sensitive postmenopausally due to estrogen reduction. Some data from prior studies are compatible with this suggestion. 84 Alternatively, central sympathetic outflow (thus plasma NE) may increase postmenopausally due to estrogen reduction and thereby overwhelm baroreceptors.
NE appears to play a more predominant role in controlling both resting SBP and DBP in females than males. This is suggested by the stronger correlation of plasma NE with both SBP and DBP in females than males. This correlation of SBP and DBP with plasma NE in females remained significant even after controlling for BMI plus age. Also, our older females had significantly higher SBP and DBP than younger females. Older females also had a plasma NE increase of about 90 pg/ml (Po0.001) relative to younger females. In contrast, plasma NE in older males was essentially unchanged from younger males, despite a marked increase in DBP in elderly males ( Figure 6 ). Others have also reported a stronger linkage of NE with BP in females than males. For example, Henry et al 85 showed that urine NE correlated significantly with BP in normotensive females, but not normotensive males. On the other hand, Goldstein et al 17 did not find augmented plasma NE levels with aging in females relative to males, nor stronger correlations of plasma NE with age in females relative to males. However, the authors 17 noted that there were several females in the 25-34-year-old group that had exceptionally high plasma NE levels (five subjects between 500-700 pg/ml). This large number of especially high NE values in young females in a study, 17 whose total number of normotensive women (n ¼ 70) was less than half of ours, could have greatly diminished the strength of the NE correlation with age in females.
In several respects, our findings with plasma NE were confirmed with urine NE. However, in a number of instances plasma and urine NE responded differently, and the correlation of plasma NE with urine NE in subjects overall was rather modest (r ¼ 0.236, P ¼ 0.002). This raises the question as to which measure is a more reliable index of whole-body sympathetic activity. Most evidence suggests that plasma NE is a more reliable index. More than half of urine NE is apparently derived from the sympathetic nerves that innervate the kidney, 86, 87 whereas plasma NE generally has a smaller contribution from local nerves. In addition, urine NE levels are influenced by more metabolic processes than are plasma NE levels, as is illustrated by the fact that only about 10% of plasma NE is excreted unchanged into urine in humans. 87 Urine NE excretion is affected by the efficiency of extraction from plasma, and activity of renal metabolic enzymes, whereas plasma NE is not.
A major reason for discrepancies between urine and plasma NE in our study may be that our urine values are corrected for creatinine (ng catecholamine/mg creatinine), but urine creatinine is affected by several parameters of this study, including age and gender. For example, we and others 85 have reported that women have higher urine creatinine levels than men. We and others have also shown that urine creatinine correlates inversely with age. In addition, older women have a significant reduction in creatinine relative to younger women, but such a significant reduction does not occur in males. However, normalization of urine analyte concentrations to creatinine is an effective way to correct excretion data for interindividual differences in water consumption and excretion. Such creatininecorrected values correlate highly (r ¼ 0.82, Po0.0001, n ¼ 87) with excretion values expressed per unit time. 88 
Glutathione
Our data suggest that GSH reduction may play a role in the larger DBP elevation in males with aging. An inverse correlation of GSH with DBP was significant only in males (r ¼ À0.352 vs À0.084) despite a roughly three-fold larger population of females. In older (above-median age) males, GSH was significantly (P ¼ 0.004) reduced by about 30% vs younger males, whereas GSH was nonsignificantly reduced by only 10% in older vs younger females, again, despite a larger female study population. Furthermore, GSH was significantly (B26%) higher in young (below-median age) males than young females, and DBP was significantly lower in young males than young females.
A study in mice suggests that the decline in GSH in several rodent tissues with aging is more dramatic in males than females. 47 Similarly, the decline in erythrocyte GSH with aging in dogs was much greater in males than females. 89 Sex differences in GSH with aging appear to reflect the differential effects of male and female sex hormones on GSH synthetic enzymes and an antioxidant action of estrogens. Levels of GSHsynthesizing enzymes in several tissues (including human erythrocytes) and plasma 90 are higher in females than males. [91] [92] [93] Levels of these GSHsynthesizing enzymes can be altered by both estrogens 94, 95 and testosterone. 96, 97 GSH is typically reduced under conditions of enhanced oxidative stress due to the enhanced destruction of GSH in the process of neutralizing free radicals. 98, 99 Estrogens appear to have direct potent antioxidant activity, 100, 101 and so may prevent the early decline in GSH that occurs in males by contributing to antioxidant defense.
One complication in determining whether the inverse relationship between GSH and BP is due to the antihypertensive action of GSH is that GSH is also inversely correlated with BMI. Since BMI is positively correlated with BP, it is conceivable that GSH may be directly functionally related to BMI rather than BP. Controlling for BMI does generally weaken our correlations of GSH with BP. However, in support of a direct GSH-regulatory role on BP, the significant reduction in GSH with aging in males and the inverse correlation of GSH with BP occur in the absence of an aging-induced BMI elevation in males. Conversely, BP increases significantly in older vs younger females, but the slight reduction in GSH in older females compared to younger females is not statistically significant despite a highly significant BMI elevation in the older females.
Obesity is associated with oxidative stress, 102, 103 which in turn can be associated with reduced levels of GSH. 98, 99 This may account for the inverse correlation between GSH and BMI. Since GSH has antihypertensive actions, 50, 51, 53, 54 it seems reasonable to speculate that, even if GSH is somewhat dependent on BMI, reductions in GSH may be one mechanism by which increased BMI elevates BP.
Pharmacological depletion of GSH in experimental animals elevates BP; [50] [51] [52] thus, our observation that GSH is inversely correlated with BP (Tables 2-5 ) may be of pathophysiological significance. Some animal data suggest that reductions in CNS GSH may increase BP by increasing the sympathetic outflow. 51 GSH in tissues, including brain, 49 is generally reduced with aging, so reduced brain GSH might be partially responsible for increased sympathetic outflow with aging.
If plasma GSH levels strongly influence, or are reflective of, brain GSH levels, then our data do not support the view that brain GSH inhibits sympathetic outflow in humans. Plasma NE was not reduced in subjects with high GSH. Young subjects with low GSH had significantly elevated BP, but reduced plasma NE relative to young high GSH subjects. Both these observations are the opposite of what one would expect if plasma GSH determines brain GSH and low brain GSH increases sympathetic outflow.
One possible explanation for our results may be that the higher BP of low-plasma (ie, peripheral) GSH subjects may have triggered a baroreceptormediated sympathetic withdrawal in an attempt to normalize BP. The presence of this counter-regulatory sympathetic withdrawal (ie, reduced plasma NE) to the higher BP of low GSH subjects supports the view that the depressor effects of GSH are peripheral in origin, rather than resulting from centrally mediated reductions in sympathetic outflow.
Body mass index
It has been postulated that the association between BMI and BP may be mediated by obesity-induced increases in sympathetic activity. Our data do not support this view. If aging-associated increases in BMI raise BP simply by enhancing sympathetic activity, one would have expected that subjects with higher (above median) BMI would have higher plasma and urine NE levels, but this was not the case. Furthermore, if BMI enhances BP mainly by raising sympathetic activity, one might also have expected a significant positive correlation between NE and BMI, but this was not the case in subjects overall, or in such subgroups as males, females, young subjects, or old subjects. In fact, in older subjects, and older females, there was a significant inverse correlation of NE with BMI.
One potential mechanism mediating the negative correlation of BMI with plasma NE in older females may be that enhanced sympathetic activity in this group increases the metabolic rate, thereby reducing BMI. We found enhanced sympathetic activity in older females (ie, elevated NE), and others have reported increased muscle sympathetic activity in postmenopausal females. 61, 70, 71 However, our finding that older females were significantly (Po0.001) heavier than younger females in spite of markedly increased sympathetic activity does not appear to support the concept of enhanced sympathetic activity-mediated thermogenesis in older females. Furthermore, the propensity towards weight gain does not appear to be reduced after menopause. 104, 105 An alternative explanation for the negative correlation between plasma NE and BMI in our older females may be that baroreceptor-mediated reductions in sympathetic activity more effectively lower the BP in this group. If increased BMI raises BP by a solely peripheral mechanism, then one might expect a negative correlation between BMI and NE since baroreceptors would act to reduce sympathetic outflow in relation to the magnitude of the BMIinduced BP increase.
If baroreceptor-mediated reductions in sympathetic activity counteract the effect of increased BMI on SBP most effectively in older subjects, one would expect that there would be less SBP elevation with increased BMI in older subjects, and a poorer correlation of SBP with BMI in older subjects. Both of these predictions are supported by our data. The correlation of SBP with BMI in the young (belowmedian age) subjects was very strong (r ¼ 0.517, Po0.0001), but it was not even statistically significant in the older subjects (r ¼ 0.182, P ¼ 0.071). Similarly, younger subjects with high BMI had SBP that was 10 mmHg higher (Po0.001) than younger subjects with low BMI, whereas older subjects with high BMI had a nonsignificant (P ¼ 0.091) increase in SBP that was half as large. Comparable results were obtained when only females were included in these types of analyses.
Also, if the dominant relationship of NE to BMI in the elderly is that of baroreceptor-mediated sympathetic withdrawal to the pressor effects of increased BMI, then one would expect that the correlation of BMI with BP in the elderly would be enhanced by correcting for plasma NE. In support of this view, nonsignificant correlations between BMI and SBP became statistically significant in older subjects after correcting for plasma NE, but this did not occur in younger subjects. Similarly, correcting for plasma NE enhanced the correlation of SBP with BMI to significance in older females, but not younger females.
Since there was no significant inverse correlation between plasma or urine NE and BMI in our subjects overall, it seems likely that, in most subjects, obesity may lead to a modest increase in sympathetic drive (perhaps via leptin), which is masked by a baroreceptor-mediated sympathetic withdrawal in response to peripherally located, obesity-induced BP elevation. Baroreceptor-mediated sympathetic withdrawal seems to be the predominant response to the peripheral pressor effects of obesity, since adjustment for variations in plasma NE tended to enhance the strength of the correlations between BMI and BP in subjects overall.
As was mentioned earlier, elderly females have increased SBP relative to young females, yet have higher plasma NE levels than younger females. This would appear to suggest baroreceptor dysfunction in elderly females. These results appear to conflict with what appears to be a strong and highly functional baroreceptor response to the pressor effects of obesity in elderly females. Perhaps the simplest explanation for this apparent paradox is that certain baroreceptor pathways are highly functional in elderly females, whereas others may be disrupted by postmenopausal estrogen depletion.
There was a strong positive correlation of age with both SBP and DBP that remained significant even after controlling for variations in plasma NE, GSH, or BMI. So, it appears likely that changes in sympathetic activity, GSH, and body mass do not fully account for BP increases that occur with aging. It seems likely that the thickening and stiffening of blood vessels that commonly accompany aging may also contribute to age-associated BP elevations. This view seems to be supported by our MLR analyses that account for the combined contributions of BMI, age, plasma NE, and GSH to BP. The MLR data show a greater contribution of these four factors to BP in younger subjects than older subjects, which is compatible with a greater contribution of other factors, such as vascular stiffening to BP in older subjects. Of note, the combined contribution of BMI, age, plasma NE, and GSH to both SBP and DBP as determined by MLR is greater in young males than young females (DBP r ¼ 0.717 vs 0.477; SBP r ¼ 0.726 vs 0.542) ( Table 5 ).
Conclusions and perspectives
The results of the present study are novel in several respects (summary in Table 7 ). This study is the first to show that plasma GSH levels in man correlate inversely with resting BP, that this relationship is strongest in men, and that plasma GSH levels are (Table 6 ). Rise in SBP with age more prominent in women ( Figure 6 ). Body mass index (BMI) BMI rises with aging.
1,2
Increased BMI with aging (Figures 2 and 6 ). BMI associated with higher BP (Figure 5 ). h 2 ¼ 8474% (Table 6 , Figure 1 ). Blood pressure (BP)
BP rises with aging.
1,2
BP increased with aging (Figures 2 and 6 ). BP increased with higher BMI ( Figure 5 ). Higher BP associated with higher NE (Figure 7) . h 2 ¼ B18-28% (Table 6 , Figure 1 ). Norepinephrine (NE) NE release increases with aging. [20] [21] [22] [23] [24] [25] NE increased with aging (Figures 2 and 6 ). Increased NE pl in younger subjects with lower GSH (Figure 4 ). Higher BP associated with higher NE (Figure 7) . h 2 ¼ B49-59% (Table 6 , Figure 1 ).
Glutathione (GSH)
Decline in GSH with aging in animals. [42] [43] [44] [45] [46] [47] [48] [49] GSH depletion in animals raises BP. [50] [51] [52] GSH decreased with aging (Figures 2 and 6 ). Increased NE pl in younger subjects with lower GSH (Figure 4 ). h 2 ¼ 6878% (Table 6 , Figure 1 ). Figure 9 Proposed pathophysiology. Flow chart illustrating the proposed major causal relationships among BP, age, BMI, GSH, and NE based on conclusions from the data of this study. ( þ ) above arrow indicates a positive or incremental action on the parameter being pointed to. (-) above arrow indicates a negative or decremental action on the parameter being pointed to. The relationship of plasma NE with BP is particularly strong in elderly females, whereas the effect of GSH on BP appears most pronounced in young males.
highly heritable. This study is also the first to provide compelling evidence that increased sympathetic activity with aging contributes to BP increases with aging, especially in women. In addition, this study is the first to provide strong evidence that the pressor effect of increased BMI is primarily peripheral in origin and leads to a baroreceptor-mediated sympathetic withdrawal, most prominently in females. Finally, this study establishes the substantial heritability of urinary NE excretion.
Are our conclusions applicable to common variations of BP within the general population? Twin pairs are generally considered to represent a random sample of the population. 106, 107 Our studies spanned a large age range and both genders, and were based in part on recruitment through a population-based birth registry. 77, 108 However, the study was voluntary and based in part on response to newspaper advertisements; hence, we cannot completely exclude unexpected/inadvertent ascertainment bias as an influence on our results.
The interrelationships among BP, aging, BMI, NE, and GSH suggested by our data are summarized in Figure 9 . We conclude that increases in both sympathetic activity and BMI play important roles in the BP elevation with aging, especially in females. In elderly females, baroreceptor-mediated reductions in sympathetic activity appear to counteract the systolic pressor effects of increased BMI. Reductions in GSH with aging also appear to play a role in aging-induced BP increases, especially in younger adults and males. Plasma levels of NE and GSH, urine NE, and BMI are all highly heritable.
